X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (160) 160
ophthalmology (117) 117
sorsbys-fundus-dystrophy (78) 78
macular degeneration (72) 72
female (68) 68
sorsbys fundus dystrophy (65) 65
animals (58) 58
male (58) 58
tissue inhibitor (56) 56
sorsby fundus dystrophy (54) 54
macular degeneration - genetics (52) 52
aged (50) 50
mutation (49) 49
adult (48) 48
index medicus (48) 48
middle aged (47) 47
biochemistry & molecular biology (38) 38
retinal-pigment epithelium (34) 34
metalloproteinases-3 timp3 (33) 33
aged, 80 and over (30) 30
pedigree (30) 30
tissue inhibitor of metalloproteinase-3 - genetics (30) 30
fundus oculi (28) 28
mice (28) 28
phenotype (28) 28
sorsby's fundus dystrophy (28) 28
timp-3 (28) 28
age-related macular degeneration (27) 27
retinitis-pigmentosa (27) 27
eye diseases (25) 25
gene (25) 25
genetic structures (23) 23
genetics & heredity (23) 23
macular degeneration - pathology (23) 23
sense organs (23) 23
bruchs membrane (21) 21
cell biology (21) 21
expression (21) 21
fluorescein angiography (21) 21
retina (19) 19
retinal degeneration - genetics (19) 19
retinal pigment epithelium (19) 19
analysis (18) 18
macular degeneration - physiopathology (18) 18
tissue inhibitor of metalloproteinase-3 (18) 18
tissue inhibitor of metalloproteinase-3 - metabolism (18) 18
dark-adaptation (17) 17
age-related maculopathy (16) 16
angiogenesis (16) 16
disease (16) 16
extracellular matrix (16) 16
extracellular-matrix (16) 16
family (16) 16
macular degeneration - diagnosis (16) 16
visual acuity (16) 16
drusen (15) 15
electroretinography (15) 15
macular degeneration - metabolism (15) 15
matrix metalloproteinases (15) 15
medicine, research & experimental (15) 15
retinal degeneration (15) 15
age (14) 14
apoptosis (14) 14
choroidal neovascularization (14) 14
eye proteins - genetics (14) 14
localization (14) 14
timp3 (14) 14
blotting, western (13) 13
dark adaptation (13) 13
endothelial growth-factor (13) 13
genetic linkage (13) 13
neovascularization (13) 13
retina - pathology (13) 13
degeneration (12) 12
genetic aspects (12) 12
macular dystrophy (12) 12
molecular sequence data (12) 12
article (11) 11
cone-rod dystrophy (11) 11
gene expression (11) 11
genetics (11) 11
human tissue inhibitor (11) 11
maculopathy (11) 11
retina - metabolism (11) 11
retinal degeneration - physiopathology (11) 11
retinitis pigmentosa (11) 11
vitamin-a (11) 11
vitamin-a-deficiency (11) 11
adolescent (10) 10
cells, cultured (10) 10
chromosome mapping (10) 10
complement factor-h (10) 10
dominant retinitis-pigmentosa (10) 10
genes, dominant (10) 10
genotype (10) 10
optical coherence tomography (10) 10
physiological aspects (10) 10
pigment epithelium of eye - metabolism (10) 10
proteins (10) 10
proteins - genetics (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 03/2013, Volume 8, Issue 3, p. e55667
Tissue inhibitors of metalloproteinases (TIMPs) while originally characterized as inhibitors of matrix metalloproteinases (MMPs) have recently been shown to... 
TIMP-3 | LOCALIZATION | UNUSUAL CLINICAL-FEATURES | GENE | VEGF | MULTIDISCIPLINARY SCIENCES | MUTATION | FUNCTIONAL DOMAINS | SORSBYS-FUNDUS-DYSTROPHY | ENDOTHELIAL GROWTH-FACTOR | FAMILY | Phosphorylation | Humans | Choroidal Neovascularization - etiology | Tissue Inhibitor of Metalloproteinase-3 - chemistry | Bruch Membrane - blood supply | Tissue Inhibitor of Metalloproteinase-3 - antagonists & inhibitors | Vascular Endothelial Growth Factor Receptor-2 - genetics | Solid-Phase Synthesis Techniques | Bruch Membrane - drug effects | Peptides - chemical synthesis | Tissue Inhibitor of Metalloproteinase-3 - metabolism | Laser Coagulation - adverse effects | Angiogenesis Inhibitors - chemical synthesis | Tissue Inhibitor of Metalloproteinase-3 - genetics | Vascular Endothelial Growth Factor Receptor-1 - genetics | Bruch Membrane - injuries | Mice, Inbred C57BL | Cells, Cultured | Angiogenesis Inhibitors - pharmacology | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Choroidal Neovascularization - prevention & control | Peptides - pharmacology | Gene Expression Regulation - drug effects | Animals | Choroidal Neovascularization - metabolism | Signal Transduction - drug effects | Mice | Choroidal Neovascularization - genetics | Endothelium, Vascular | Physiological aspects | Genetic aspects | Research | Neovascularization | Proteases | Vascular endothelial growth factor | Cell proliferation | Diabetic retinopathy | Matrix metalloproteinases | Peptides | Amino acids | Tissue inhibitor of metalloproteinase 3 | Vascularization | Proteins | Angiogenesis | Synthetic peptides | Lesions | Localization | Binding | Medical research | Endothelial cells | Vascular endothelial growth factor receptors | Medicine | Signaling | Inhibitors | Mutation | Angiogenesis inhibitors | Cell migration | Structure-function relationships
Journal Article
Archivos de la Sociedad Espanola de Oftalmologia, ISSN 0365-6691, 06/2013, Volume 88, Issue 6, pp. 240 - 243
Case report: The case is presented of a 32-year-old man referring to metamorphopsia and blurred vision in both eyes for 3 days. Best corrected visual acuity of... 
TIMP-3 | Sorsby's fundus dystrophy | Choroidal neovascularization | Optical coherence tomography | Antiangiogenic therapy | Auto-fluorescence
Journal Article
European Journal of Human Genetics, ISSN 1018-4813, 10/2013, Volume 21, Issue 10, pp. 1152 - 1157
Age-related macular degeneration (AMD) is a leading cause of irreversible central visual loss in the elderly. A recent genome-wide association studies (GWAS)... 
phenotype | TIMP3 | Blue Mountains Eye Study | single-nucleotide polymorphism | age-related macular degeneration | Age-Related Eye Diseases Study | RISK-FACTORS | BIOCHEMISTRY & MOLECULAR BIOLOGY | BRUCHS MEMBRANE | VISUAL-LOSS | SORSBYS FUNDUS DYSTROPHY | BLUE MOUNTAINS EYE | MUTATION | DISEASE | GENETICS & HEREDITY | TISSUE INHIBITOR | AREDS | METALLOPROTEINASES-3 TIMP3 | Cell Line | Genetic Predisposition to Disease | Geographic Atrophy - genetics | Geographic Atrophy - diagnosis | Humans | Middle Aged | RNA, Messenger - genetics | Male | Wet Macular Degeneration - genetics | RNA, Messenger - metabolism | Synapsins - genetics | Case-Control Studies | Pigment Epithelium of Eye - metabolism | Wet Macular Degeneration - diagnosis | Phenotype | Geographic Atrophy - metabolism | Wet Macular Degeneration - metabolism | Tissue Inhibitor of Metalloproteinase-3 - metabolism | Aged, 80 and over | Female | Heterozygote | Aged | Polymorphism, Single Nucleotide | Tissue Inhibitor of Metalloproteinase-3 - genetics | Transcription | Retina | Genomes | Tissue inhibitor of metalloproteinase 3 | Epidemiology | Retinal pigment epithelium | Macular degeneration | Eye | Atrophy | Immunology | Genetics | Physiology | Degeneration | Metalloproteinase | Vascular endothelial growth factor | Age | Fetuses | Epithelium | Gene expression | Statistics | Polymerase chain reaction | Studies | Synapsin | Alleles | Eye diseases | Mutation | Geriatrics
Journal Article
Ophthalmologe, ISSN 0941-293X, 1998, Volume 95, Issue 5, pp. 287 - 290
Journal Article